Potential role of type i interferons in the treatment of pituitary adenomas

Reviews in Endocrine and Metabolic Disorders

Volumn 10, Issue 2, 2009, Pages 125-133

  Vitale, Giovanni ^a,b   Caraglia, Michele ^c   Van Koetsveld, Peter M ^b   Maroni, Paola ^a,d   Marra, Monica ^c   Colao, Annamaria ^e   Lamberts, Steven W J ^b   Cavagnini, Francesco ^a   Hofland, Leo J ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

ACTH; GH; Hypothalamic pituitary function; Pituitary adenomas; Type I interferons

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; ALPHA2B INTERFERON; ANGIOPEPTIN; BETA INTERFERON; BETA1A INTERFERON; CORTICOTROPIN; DEXAMETHASONE; FOLLITROPIN; GROWTH HORMONE; INTERFERON BETA SERINE; LUTEINIZING HORMONE; OCTREOTIDE; PASIREOTIDE; PEGINTERFERON; PROLACTIN; RECEPTOR SUBUNIT; THYROTROPIN;

AUTOIMMUNE DISEASE; DOSE RESPONSE; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFECT; DRUG MECHANISM; FATIGUE; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HEPATITIS B; HEPATITIS C; HORMONE RELEASE; HUMAN; HYPERTHYROIDISM; HYPOPHYSIS ADENOMA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHYROIDISM; KIDNEY DISEASE; LIVER DISEASE; MALAISE; MENTAL DISEASE; MULTIPLE SCLEROSIS; NONHUMAN; PROTEIN FUNCTION; REVIEW; SINGLE DRUG DOSE; TREATMENT DURATION;

ANTINEOPLASTIC AGENTS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERFERON TYPE I; PITUITARY NEOPLASMS; PITUITARY-ADRENAL SYSTEM; RECEPTOR, INTERFERON ALPHA-BETA;

EID: 67349247100     PISSN: 13899155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11154-008-9083-3     Document Type: Review

References (72)

1. S Pestka 2004 Interferons, interferon-like cytokines and their receptors Immunol Rev. 202 8 32 (Pubitemid 39576902)
2. EC Borden GC Sen G Uze RH Silverman RM Ransohoff GR Foster 2007 Interferons at age 50: past, current and future impact on biomedicine Nat Rev Drug Discov. 6 975 90 (Pubitemid 350201788)
3. J Bekisz H Schmeisser J Hernandez ND Goldman KC Zoon 2004 Human interferons alpha, beta and omega Growth Factors. 22 243 51 (Pubitemid 40123402)
4. E De Maeyer J De Maeyer-Guignard 1998 Type I interferons Int Rev Immunol. 17 53 73 (Pubitemid 29014545)
5. S Pestka 1997 The interferon receptors Semin Oncol. 24 S9-18 S9-40 (Pubitemid 27268607)
6. P Domanski M Witte M Kellum M Rubinstein R Hackett P Pitha 1995 Cloning and expression of a long form of the beta subunit of the interferon alpha beta receptor that is required for signaling J Biol Chem. 270 21606 11
7. B Cohen D Novick S Barak M Rubinstein 1995 Ligand-induced association of the type I interferon receptor components Mol Cell Biol. 15 4208 14
8. C Schindler JE Darnell Jr 1995 Transcriptional responses to polypeptide ligands: the JAK-STAT pathway Annu Rev Biochem. 64 621 51
9. JN Ihle 1996 STATs: signal transducers and activators of transcription Cell 84 331 34 (Pubitemid 26058558)
10. JE Darnell Jr 1997 STATs and gene regulation Science 277 1630 5
11. K Imada WJ Leonard 2000 The Jak-STAT pathway Mol Immunol. 37 1 11 (Pubitemid 30316189)
12. K Takeda S Akira 2000 STAT family of transcription factors in cytokine-mediated biological responses Cytokine Growth Factor Rev. 11 199 207 (Pubitemid 30337459)
13. JE Darnell IM Kerr GR Stark 1994 Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins Science 264 1415 21 (Pubitemid 24217131)
14. A Meinke F Barahmand-Pour S Wohrl D Stoiber T Decker 1996 Activation of different Stat5 isoforms contributes to cell type-restricted signaling in response to interferons Mol Cell Biol. 16 6937 45 (Pubitemid 26389753)
15. PK Janick 1992 Binding of human alpha-interferon in the brain tissue membranes of rat Res Commun Chem Pathol Pharmacol. 75 117 20
16. NUD Khan KAF Pulford MA Farquharson A Howatson C Stewart R Jackson 1989 The distribution of immunoreactive interferon-alpha in normal human tissues Immunology 66 201 6 (Pubitemid 19065794)
17. H Gisslinger T Svoboda M Clodi B Gilly H Ludwig L Havelec 1993 Interferon-alpha stimulates the hypothalamic-pituitary-adrenal axis in vivo and in vitro Neuroendocrinology 57 489 95 (Pubitemid 23170154)
18. J Raber GF Koob FE Bloom 1997 Interferon-alpha and transforming growth factor-beta 1 regulate corticotropin-releasing factor release from the amygdala: comparison with the hypothalamic response Neurochem Int. 30 455 63 (Pubitemid 27136027)
19. JC Felger O Alagbe F Hu D Mook AA Freeman MM Sanchez 2007 Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression Biol Psychiatry. 62 1324 33 (Pubitemid 350060899)
20. N Dafny PB Yang 2005 Interferon and central nervous system Eur J Pharmacol. 523 1 15 (Pubitemid 41562371)
21. EP Corssmit R Heijligenberg E Endert MT Ackermans HP Saverwein JA Romijn 1996 Endocrine and metabolic effects of interferon-alpha in humans J Clin Endocrinol Metab. 81 3265 9 (Pubitemid 26296200)
22. MU Goebel J Baase V Pithan M Exton B Saller M Schedlowski 2002 Acute interferon b-1b administration alters hypothalamic-pituitary-adrenal axis activity, plasma cytokines and leukocyte distribution in healthy subjects Psychoneuroendocrinology 27 881 92 (Pubitemid 35279760)
23. Y Ohno M Fujimoto A Nishimura N Aoki 1998 Change of peripheral levels of pituitary hormones and cytokines after injection of interferon (IFN)-b in patients with chronic hepatitis C J Clin Endocrinol Metab. 83 3681 7 (Pubitemid 28500909)
24. A Barbarino S Colasanti SM Corsello M Satta S Della Casa CA Rota 1995 Dexamethasone inhibition of interferon-alpha 2-induced stimulation of cortisol and growth hormone secretion in chronic myeloproliferative syndrome J Clin Endocrinol Metab. 80 1329 32
25. GM Asnis R De La Garza II 2006 Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches J Clin Gastroenterol. 40 322 35 (Pubitemid 44309525)
26. JL Taylor SE Grossberg 1998 The effects of interferon-alpha on the production and action of other cytokines Semin Oncol. 25 Suppl 1 23 9 (Pubitemid 28093152)
27. H Shimizu K Ohtani N Sato T Nagamine M Mori 1995 Increase in serum interleukin-6, plasma ACTH and serum cortisol levels after systemic interferon-alpha administration Endocr J. 42 551 6
28. MC Wichers G Kenis GH Koek G Robaeys NA Nicolson M Maes 2007 Interferon-a-induced depressive symptoms are related to changes in the cytokine network but not to cortisol J Psychosom Res. 62 207 14 (Pubitemid 46161588)
29. CD John JC Buckingham 2003 Cytokines: regulation of the hypothalamopituitary-adrenocortical axis Curr Opin Pharmacol. 3 78 84
30. AV Turnbull CL Rivier 1999 Regulation of the hypothalamic-pituitary adrenal axis by cytokines: actions and mechanisms of action Physiol Rev. 79 1 71 (Pubitemid 29056948)
31. A Ericsson KJ Kovacs PE Sawchenko 1994 A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons J Neurosci. 14 897 913 (Pubitemid 24043940)
32. KM Buller Y Xu TA Day 1998 Indomethacin attenuates oxytocin and hypothalamic-pituitary-adrenal axis responses to systemic interleukin-1b J Neuroendocrinol. 10 519 28 (Pubitemid 28310598)
33. S Lacroix S Rivest 1997 Functional circuitry in the brain of immune-challenged rats: partial involvement of prostaglandins J Comp Neurol. 387 307 24 (Pubitemid 27430353)
34. FT Bergh T Kümpfel A Yassouridis C Lechner F Holsboer C Trenkwalder 2007 Acute and chronic neuroendocrine effects of interferon-b1a in multiple sclerosis Clin Endocrinol. 66 295 303 (Pubitemid 46096152)
35. L Capuron CL Raison DL Musselman DH Lawson CB Nemeroff AH Miller 2003 Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy Am J Psychiatry. 160 1342 5 (Pubitemid 41070955)
36. W Romanowski R Braczkowski J Kosiewicz I Korzonek E Nowakowska-Zajdel M Muc-Wierzgon 2006 Changes in growth hormone (GH) messenger RNA (GH mRNA) expression in the rat anterior pituitary after single interferon (IFN) alfa administration Endokrynol Pol. 57 482 6
37. U Plockinger D Kruger A Bergk V Weich B Wiedenmann T Berg 2007 Hepatitis-C patients have reduced growth hormone (GH) secretion which improves during long-term therapy with pegylated interferon-a Am J Gastroenterol. 102 2724 31 (Pubitemid 350179318)
38. MR Stjernholm RN Alsever P Beck 1975 Growth hormone release after synthetic 1-24 ACTH: effects of estrogen and sex J Clin Endocrinol Metab. 40 516 8
39. FF Casanueva B Burguera MA Tome L Lima JA Tresguerres J Devesa 1988 Depending on the time of administration, dexamethasone potentiates or blocks growth hormone-releasing hormone-induced growth hormone release in man Neuroendocrinology 47 46 9 (Pubitemid 18001544)
40. H Muller C Hiemke E Hammes G Hess 1992 Sub-acute effects of interferon-alpha 2 on adrenocorticotrophic hormone, cortisol, growth hormone and prolactin in humans Psychoneuroendocrinology 17 459 65 (Pubitemid 23015015)
41. E Baudin P Marcellin M Pouteau N Colas-Linhart JP Le Floch C Lemmonier 1993 Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C Clin Endocrinol (Oxf). 39 657 61 (Pubitemid 24010954)
42. G Mazziotti F Sorvillo G Stornaiuolo M Rotondi F Morisco M Ruberto 2002 Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: a prospective study J Endocrinol Invest. 25 624 30
43. M Lisker-Melman AM Di Bisceglie SJ Usala B Weintraub LM Murray H Hoofnagle 1992 Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa Gastroenterology 102 2155 60
44. C Carella G Mazziotti G Amato LE Braverman E Roti 2004 Interferon-a-related thyroid disease: pathophysiological, epidemiological, and clinical aspects J Clin Endocrinol Metab. 89 3656 61 (Pubitemid 39071450)
45. N Caraccio A Dardano F Manfredonia L Manca L Pasquali A Iudice 2005 Long-term follow-up of 106 multiple sclerosis patients undergoing interferon-beta 1a and 1b therapy: predictive factors of thyroid disease development and duration J Clin Endocrinol Metab. 90 4133 7 (Pubitemid 41058187)
46. PJ Tebben JL Atkinson BW Scheithauer D Erickson 2007 Granulomatous adenohypophysitis after interferon and ribavirin therapy Endocr Pract. 13 2 169 75
47. E Ridruejo AF Chritiensen OG Mando 2006 Central hypothyroidism and hypophysitis during treatment of chronic hepatitis C with pegylated interferon alpha and ribavirin Eur J Gastroenterol Hepat. 18 693 4 (Pubitemid 43804656)
48. CM Barros JG Betts WW Thatcher PJ Hansen 1992 Possible mechanisms for reduction of circulating concentrations of progesterone by interferon-a in cows: effects on hyperthermia, luteal cells, metabolism of progesterone and secretion of LH J Endocrinol. 133 175 82
49. EPM Corssmit E Endert HP Sauerwein JA Romijn 2000 Acute effects of interferon-a administration on testosterone concentrations in healthy men Eur J Endocrinol. 143 371 374
50. M Orava K Cantell R Vihko 1986 Treatment with preparations of human leukocyte interferon decreases serum testosterone concentrations in men Int J Cancer. 38 295 6 (Pubitemid 16036297)
51. M Piazza G Tosone G Borgia R Orlando G Fenzi M Vitale 1997 Long-term interferon-alpha therapy does not affect sex hormones in males with chronic hepatitis C J Interferon Cytokine Res. 17 525 9 (Pubitemid 27475917)
52. T Barreca A Picciotto R Franceschini G Varagona A Garibaldi F Valle 1993 Sex hormones and sex-hormone binding globulin in males with chronic viral hepatitis during recombinant interferon-alpha 2b therapy J Interferon Res. 13 209 11 (Pubitemid 23182678)
53. M Yamaguchi K Koike N Matsuzaki Y Yoshimoto T Taniguchi A Miyake 1991 The interferon family stimulates the secretions of prolactin and interleukin-6 by the pituitary gland in vitro J Endocrinol Invest. 14 457 61
54. SC Bohnet TR Traynor JA Majde B Kacsoh JM Krueger 2004 Mice deficient in the interferon type I receptor have reduced REM sleep and altered hypothalamic hypocretin, prolactin and 2¢, 5¢-oligoadenylate synthetase expression Brain Res. 1027 117 25 (Pubitemid 39371001)
55. TTT Kumai M Tanaka M Watanabe H Shimizu S Kobayashi 2000 Effect of interferon-alpha on tyrosine hydorxylase and catecholamine levels in the brain of rats Life Sci. 67 663 9 (Pubitemid 30451905)
56. MP Gillam ME Molitch G Lombardi A Colao 2006 Advances in the treatment of prolactinomas Endocr Rev. 27 485 534 (Pubitemid 44213229)
57. A Colao R Pivonello P Cappabianca G Vitale G Lombardi 2003 The treatment algorithm of acromegaly J Endocrinol Invest. 26 8 Suppl 39 45
58. A Colao G Arnaldi P Beck-Peccoz S Cannavò R Cozzi E degli Uberti 2007 Pegvisomant in acromegaly: why, when, how J Endocrinol Invest. 30 693 9 (Pubitemid 350104101)
59. S Melmed 2006 Medical progress. Acromegaly N Engl J Med. 355 2558 73
60. Murray RD, Melmed S. A critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly. J Clin Endocrinol Metab. 2008, (in press).
61. CA Jaffe 2006 Clinically non-functioning pituitary adenoma Pituitary 9 317 21
62. M Labeur M Theoodoropoulou C Sievers M Paez-Pereda V Castillo E Aret 2006 New aspects in the diagnosis and treatment of Cushing disease Front Horm Res. 35 169 78
63. D Morris A Gorssman 2002 The medical management of Cushing's syndrome Ann N Y Acad Sci. 970 119 33 (Pubitemid 35286089)
64. M Katahira Y Iwasaki Y Aoki Y Oiso H Saito 1998 Cytokine regulation of the rat proopiomelanocortin gene expression in AtT-20 cells Endocrinology 139 2414 22 (Pubitemid 28513767)
65. R Zennaro EG Petracca R Paolini E Ramazzina 1996 Normalization of the prolactin values during alfa-interferon therapy: the considerations with a female patient with anti-HCV-positive chronic hepatitis and prolactin-secreting hypophyseal microadenoma Clin Ter. 147 169 71 (Pubitemid 26412601)
66. LJ Hofland WW de Herder J Zuijderwijk P Uitterlinden PM van Koetsveld SW Lamberts 1999 Interferon-alpha-2a is a potent inhibitor of hormone secretion by cultured human pituitary adenomas J Clin Endocrinol Metab. 84 3336 43 (Pubitemid 30646965)
67. G Vitale CH van Eijck PM van Koetsveld JJ Erdmann EJ Speel K van der Wansem 2007 Type I interferons in the treatment of pancreatic cancer: mechanisms of action and role of related receptors Ann Surg. 246 259 68 (Pubitemid 47196524)
68. G Vitale WW de Herder PM van Koetsveld M Waaijers W Schoordijk E Croze 2006 Interferon-beta is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitro Cancer Res. 66 554 62 (Pubitemid 43166064)
69. PM van Koetsveld G Vitale WW de Herder RA Feelders K van der Wansem M Waaijers 2006 Potent inhibitory effects of type i interferons on human adrenocortical carcinoma cell growth J Clin Endocrinol Metab. 91 4537 43
70. TG Johns IR Mackay KA Callister PJ Hertzog RJ Devenish AW Linnane 1992 Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon beta J Natl Cancer Inst. 84 1185 90
71. PA Buchwalder T Buclin I Trinchard A Munafo J Biollaz 2000 Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers J Interferon Cytokine Res. 20 857 66
72. DE Mager B Neuteboom WJ Jusko 2005 Pharmacokinetics and pharmacodynamics of PEGylated IFN-beta 1a following subcutaneous administration in monkeys Pharm Res. 22 58 61 (Pubitemid 40558146)